Persistence at 12 months with denosumab in postmenopausal women with osteoporosis: interim results from a prospective observational study.

Persistence at 12 months with denosumab in postmenopausal women with osteoporosis: interim results from a prospective observational study.

Item
http://www.wikidata.org/entity/Q34863304
Update on denosumab in the management of postmenopausal osteoporosis: patient preference and adherenceFactors associated with high 24-month persistence with denosumab: results of a real-world, non-interventional study of women with postmenopausal osteoporosis in Germany, Austria, Greece, and Belgium.Persistence, adherence, and medication-taking behavior in women with postmenopausal osteoporosis receiving denosumab in routine practice in Germany, Austria, Greece, and Belgium: 12-month results from a European non-interventional studyPersistence with denosumab and persistence with oral bisphosphonates for the treatment of postmenopausal osteoporosis: a retrospective, observational study, and a meta-analysisInflammation, fracture and bone repair.Secondary prevention of fractures after hip fracture: a qualitative study of effective service delivery.GRAND-4: the German retrospective analysis of long-term persistence in women with osteoporosis treated with bisphosphonates or denosumab.Geographic variation in secondary fracture prevention after a hip fracture during 1999-2013: a UK study.Baseline Characteristics and Changes in Bone Mineral Density T-Scores of Bulgarian Women with Postmenopausal Osteoporosis Receiving Denosumab in Routine Clinical Practice.Two-year persistence and compliance with osteoporosis therapies among postmenopausal women in a commercially insured population in the United StatesPersistence with denosumab therapy in women affected by osteoporosis with fragility fractures: a multicenter observational real practice study in Italy.Persistence with denosumab and zoledronic acid among older women: a population-based cohort study.A Retrospective Longitudinal Database Study of Persistence and Compliance with Treatment of Osteoporosis in Hungary.Frequency of discontinuation of injectable osteoporosis therapies in US patients over 2 years.Medication-taking behaviour in Bulgarian women with postmenopausal osteoporosis treated with denosumab or monthly oral bisphosphonates.Real-world Management of Women with Postmenopausal Osteoporosis Treated with Denosumab: A Prospective Observational Study in the Czech Republic and SlovakiaPersistence at 24 months with denosumab among postmenopausal women with osteoporosis: results of a prospective cohort study
P2860

Persistence at 12 months with denosumab in postmenopausal women with osteoporosis: interim results from a prospective observational study.

Item
http://www.wikidata.org/entity/Q34863304
description
2014 nî lūn-bûn
@nan
2014 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Persistence at 12 months with ...... ospective observational study.
@ast
Persistence at 12 months with ...... ospective observational study.
@en
Persistence at 12 months with ...... ospective observational study.
@nl
type
label
Persistence at 12 months with ...... ospective observational study.
@ast
Persistence at 12 months with ...... ospective observational study.
@en
Persistence at 12 months with ...... ospective observational study.
@nl
prefLabel
Persistence at 12 months with ...... ospective observational study.
@ast
Persistence at 12 months with ...... ospective observational study.
@en
Persistence at 12 months with ...... ospective observational study.
@nl
P1433
P1476
P2093
P2860
P2888
P304
P31
P356
P407
P433
P478
P577
P5875
P698
P921
P932
P356
P1433
P1476
Persistence at 12 months with ...... ospective observational study.
@en
P2093
P2860
P2888
P304
P31
P356
P407
P433
P478
P577
P5875
P698
P921
P932